Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Removed disease-related topic tags 'Ovarian cancer' and related 'MedlinePlus Genetics' from the page. Core study information and trial details remain unchanged.
    Difference
    0.2%
    Check dated 2025-12-30T23:06:56.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study status is listed as Completed with Actual start date 2019-10-17 and completion date 2022-10-03. Revision v3.3.3 is noted and related topics like Ovarian cancer and MedlinePlus Genetics are added.
    Difference
    3%
    Check dated 2025-12-23T20:22:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed 'Ovarian cancer' and 'MedlinePlus Genetics' from the related topics/MeSH terms section; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-16T15:44:19.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Added related topic links: Ovarian cancer and MedlinePlus Genetics, expanding the related topics section on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-02T12:31:11.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Minor wording updates were made to the PubMed publications note to clarify auto-fill behavior, and the revision indicator was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:23:30.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Footer changes removed the government funding status notice and the 'Ovarian cancer - related topics' link. These removals do not affect the study details, enrollment criteria, or outcomes.
    Difference
    0.6%
    Check dated 2025-11-18T06:46:58.000Z thumbnail image

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.